Ipratropium Steri-Neb

Ipratropium Bromide, the active ingredient in Ipratropium Steri-Neb, is an anticholinergic (muscarinic antagonist) presented as a nebulizer solution for inhalation use. It treats chronic obstructive pulmonary disease (COPD) and asthma by relaxing airway smooth muscle and improving airflow. GNH USA supplies Ipratropium Steri-Neb as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipratropium Steri-Neb is an anticholinergic bronchodilator used to manage obstructive airway diseases. - Chronic obstructive pulmonary disease (COPD): improves lung function and reduces exacerbations. - Asthma: provides bronchodilation as an adjunct to other controller therapies. - Chronic bronchitis: lessens bronchial secretions and eases breathing.

Common Side Effects: - Cough - Dry mouth - Throat irritation - Headache

Serious or Rare Side Effects: - Paradoxical bronchospasm - Severe allergic reaction (anaphylaxis) - Urinary retention

Before using Ipratropium Steri-Neb, consider the following precautions: - Monitor respiratory status: assess for worsening symptoms. - Assess for narrow‑angle glaucoma: anticholinergic effect may increase intra‑ocular pressure. - Use with caution in patients with urinary retention or prostate enlargement. - Avoid in individuals with known hypersensitivity to ipratropium or formulation excipients. - Adjust dose in renal impairment: monitor renal function regularly. - Store at room temperature: keep in original container, protect from light and moisture.

Ipratropium Steri-Neb may interact with other medications as follows: Major Interactions (Avoid): - Combined use with other anticholinergic agents. - Concomitant use with beta‑2 agonists (monitor for additive bronchodilation). - Use with ophthalmic ipratropium preparations. Moderate Interactions (Monitor Closely): - Co‑administration with diuretics (monitor electrolyte balance). - Use with antihistamines (watch for increased sedation).